Our enterprise is the most reliable and trustworthy which is exclusively engaged in offering a wide range of Idrofos. This Idrofos is used in the prevention and treatment of osteoporosis and metastasis-associated skeletal fractures in people with cancer. Offered Idrofos is tested at laboratories so as to ensure its quality assured range. We offer this Idrofos in different air tight packaging options within stipulated time frame.
- Fast result
- No side effect
- Hypercalcaemia due to malignancy, hypercalcaemia of malignancy
- The action of ibandronate on bone tissue is based partly on its affinity for hydroxyapatite, which is part of the mineral matrix of bone.
- Nitrogen-containing bisphosphonates (such as pamidronate, alendronate, risedronate, ibandronate and zoledronate) appear to act as analogues of isoprenoid diphosphate lipids, thereby inhibiting farnesyl pyrophosphate (FPP) synthase, an enzyme in the mevalonate pathway. Inhibition of this enzyme in osteoclasts prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are essential for the post-translational farnesylation and geranylgeranylation of small GTPase signalling proteins.
- This activity inhibits osteoclast activity and reduces bone resorption and turnover
|Generic Name||Ibandronic Acid|